Latest filing published 02 Sept 2015 for ALDER BIOPHARMACEUTICALS INC, €560k.
Insider track record
No signal scores available.
SRB Associates IX L.P.: trading record in brief
This profile gathers the share dealings of SRB Associates IX L.P. in Alder Biopharmaceuticals Inc. Between 13 May 2014 and 31 August 2015, the trades on record add up to 9 filings.
Sales make up the whole of the open-market record (4 sales, €46.0M). 2015 to date brings no purchases and 4 sales.
The newest entry dates from 2 September 2015: an open-market sale of €560k, in Alder Biopharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to SRB Associates IX L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,218 shares@ US$38.7508Common StockSEC:0001179110-15-012850:0
- 1,795,752 shares0Comon StockSEC:0001179110-15-012106:2
- 42 shares0Common StockSEC:0001179110-15-012106:3
- 2,024,483 shares0Common StockSEC:0001179110-15-009362:0
- 46 shares0Common StockSEC:0001179110-15-009362:1
- 1,136,100 shares@ US$37.0213Common StockSEC:0001179110-15-008388:0
- 5,184,974 sharesCommon StockSEC:0001179110-14-008480:0
7 of 7 declarations